What we’re funding

The Australian Government will invest $5.9 million in research to help tackle the threat of antimicrobial resistance (AMR) in aged care facilities.

Desired outcomes

The purpose of this research funding is to:

  • better understand the impact patient movement has on AMR in residential aged care facility settings
  • develop new methods and approaches to prevent, detect and respond to AMR.

Key elements

This funding supports research into:

  • addressing knowledge gaps on antimicrobial resistance in residential aged care facilities
  • novel technologies to explore the use of whole genome sequencing of bacteria to determine resistance profiles and how they change in response to different treatments and behaviours
  • accelerated development of new interventions and approaches to prevent, detect and respond to resistance.

Why it’s important

  • Antimicrobial resistance is an increasing problem in Australia and world wide.
  • There are few remaining treatment options for some infections.
  • New research investment is needed to ensure existing antimicrobials are still effective and we develop new treatment options.

How to apply

Applications for this program are closed.

Last updated: 
30 July 2018